Mizuho analyst Salim Syed raised the firm’s price target on Amgen to $214 from $208 and keeps a Neutral rating on the shares. The analyst updated the firm’s model post the Q1 results.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMGN:
